Clinical trial · Interventional
Plan for Microwave Thermal Field
Research on Intelligent System of Plan for Microwave Thermal Field for Hepatocellular Carcinoma
NCT05270642CI-TRIAL-00056935unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Develop an intelligent system based on contrast-enhanced ultrasound and clinical information to help doctors automatically obtain ablation parameters (ablation needle number, ablation needle type, ablation time,ablation power) when preparing to use microwave ablation to treat hepatocellular carcinoma
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ablation | — | UNRESOLVED | — |
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Microwave Thermal guided by Plan for Microwave Thermal Field system | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- HCC patients guided by Plan for Microwave Thermal Field
- description
- The plan for HCC patients undergoing microwave ablation would be refer to Plan for Microwave Thermal Field system
- interventionNames
- Procedure: Microwave Thermal guided by Plan for Microwave Thermal Field system
Primary outcomes (2)
- measure
- MRI within 3 days after ablation
- timeFrame
- MRI within 3 days after ablation
- description
- Postoperative MRI is used to determine whether the ablation zone completely covers the tumor and whether the size is appropriate
- measure
- local tumor progression
- timeFrame
- 6 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Biopsy or clinical diagnosis of HCC 2. Complete clinical information and preoperative CEUS 3. Curative treatment Exclusion Criteria: 1. Palliative care 2. Intolerance to ablation 3. Severe coagulation disorder
References
Publications (0)
Data not yet available
No reference posted for this study.